CIK 0001653087
- Accelerated filer
- Smaller reporting company
Alector, Inc.
Sign in to watch- Ticker
- ALEC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 822933343
- Phone
- +1 415-231-5660
- Business address
- 131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Alector LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $296,087
- in 3 filings
Net −$296,087. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-07-06 | Paul Robert Chief Medical Officer | Sale | −1,000 | $37.43 | $37K | 249,495 |
| 2021-07-06 | Paul Robert Chief Medical Officer | Sale | −3,581 | $38.55 | $138K | 245,914 |
| 2021-07-06 | Paul Robert Chief Medical Officer | Sale | −10,495 | $39.20 | $411K | 235,419 |
| 2021-07-06 | Paul Robert Chief Medical Officer | Sale | −1,100 | $40.01 | $44K | 234,319 |
| 2021-07-06 | Yu Calvin Vice President, Finance | Sale | −3,334 | $34.65 | $116K | 76,686 |
| 2021-07-02 | SCHELLER RICHARD H Director | Sale | −9,981 | $31.14 | $311K | 0 |
| 2021-07-02 | Yu Calvin Vice President, Finance | Sale | −90,840 | $31.14 | $2.8M | 96,686 |
| 2021-07-02 | Yu Calvin Vice President, Finance | Sale | −20,000 | $40.02 | $800K | 76,686 |
| 2021-07-02 | King Robert Chief Development Officer | Sale | −60,000 | $31.14 | $1.9M | 522,317 |
| 2021-07-02 | Paul Robert Chief Medical Officer | Sale | −30,000 | $31.14 | $934K | 234,319 |
| 2021-07-01 | Paul Robert Chief Medical Officer | Sale | −26,726 | $22.23 | $594K | 246,993 |
| 2021-06-16 | Paul Robert Chief Medical Officer | Sale | −4,600 | $22.18 | $102K | 273,719 |
| 2021-06-15 | Paul Robert Chief Medical Officer | Sale | −30,000 | $22.07 | $662K | 273,719 |
| 2021-06-08 | Paul Robert Chief Medical Officer | Sale | −16,175 | $19.00 | $307K | 276,719 |
| 2021-06-08 | Paul Robert Chief Medical Officer | Sale | −2,200 | $19.89 | $44K | 274,519 |
| 2021-06-08 | Paul Robert Chief Medical Officer | Sale | −800 | $20.83 | $17K | 273,719 |
| 2021-06-02 | Yu Calvin Vice President, Finance | Sale | −1,844 | $17.77 | $33K | 126,686 |
| 2021-05-21 | Paul Robert Chief Medical Officer | Sale | −14,975 | $18.14 | $272K | 273,719 |
| 2021-05-18 | Paul Robert Chief Medical Officer | Sale | −4,200 | $18.04 | $76K | 273,719 |
| 2021-04-07 | Paul Robert Chief Medical Officer | Sale | −22,255 | $19.19 | $427K | 213,764 |
Page 7 of 13 · 249 trades